Web Version

Dear Researcher,

With the growing recognition that circulating cell-free DNA (cfDNA) can provide critical information on diseases that are normally difficult to detect with standard approaches - including cancer - the interest in liquid biopsy methods for biomarker discovery and disease research is on the rise. In addition to cfDNA, exosomes are also a rich source of biomarkers that are amenable to the straightforward liquid biopsy approach.

To facilitate biomarker discovery in liquid biopsies, BioCat offers comprehensive tools for the complete workflow from the collection and preservation of blood or urine through the enrichment, purification and NGS analysis of cfDNA, cfRNA and exosomal DNA or RNA.

Biomarker Discovery in Blood and Urine

  • Blood & Urine Collection and Preservation
  • Circulating cell-free DNA Isolation
  • Circulating cell-free RNA Isolation
  • Exosome Isolation
  • Exosomal DNA and RNA Isolation
  • NGS DNA Library Preparation

*This special offer expires December 31, 2017

BioCat GmbH

Im Neuenheimer Feld 584
D-69120 Heidelberg
Tel:  +49 (0) 6221 7141516
Fax: +49 (0) 6221 7141529
Email: info@biocat.com
Web: https://www.biocat.com